Tak Mak

Professor of Medical Biophysics, University of Toronto; Director of the Advanced Medical Discovery Institute; Director of the Campbell Family Institute for Breast Cancer Research; foreign associate of the National Academy of Sciences and fellow of the Royal Society Mak is a preeminent researcher of the biology of the immune system, the biology of apoptosis and the pathogenesis of cancer. His key contributions include: Discovering the T-Cell receptor Characterizing the tumorigenic functions of the tumor suppressor protein p53 and the kinase Chk2 Identifying CPT1C as a tumor-specific gene product that plays an important role in the utilization of fatty acids as an alternative energy source of cancer cells Discovery of the function of CTLA-4.

Tak Mak is the Founders at Agios Pharmaceuticals, based in North America. With a background in Biotechnology, Tak Mak has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.